A. Liuzzi

发表

Evaluation of a Multisensor Armband in Estimating Energy Expenditure in Obese Individuals

Paolo Marzullo, E. Maltezos, P. Marzullo, 2006, Obesity.

Genome-wide meta-analysis identifies 11 new loci for anthropometric traits and provides insights into genetic architecture

Christian Gieger, Jianxin Shi, Inês Barroso, 2013, Nature Genetics.

Glucose homeostasis in acromegaly: effects of long‐acting somatostatin analogues treatment

A. Liuzzi, F. Leonetti, M. Ribaudo, 2003, Clinical endocrinology.

The impact of growth hormone/insulin-like growth factor-I axis and nocturnal breathing disorders on cardiovascular features of adult patients with Prader-Willi syndrome.

P. Marzullo, A. Liuzzi, R. Vettor, 2005, The Journal of clinical endocrinology and metabolism.

FREE THYROID HORMONE LEVELS AND TSH RESPONSE TO TRH IN PATIENTS WITH AUTONOMOUS THYROID ADENOMATA AND NORMAL T3 AND T4

M. Losa, A. Liuzzi, S. Lerro, 1985, Clinical endocrinology.

Disabling Obesity

P. Capodaglio, A. Liuzzi, J. Faintuch, 2012, Springer Berlin Heidelberg.

Systemic hypertension and impaired glucose tolerance are independently correlated to the severity of the acromegalic cardiomyopathy.

P. Marzullo, A. Colao, A. Colao, 2000, The Journal of clinical endocrinology and metabolism.

Quality of life, disability, and body mass index are related in obese patients

M. Leonardi, L. Pasqualinotto, A. Raggi, 2011, International journal of rehabilitation research. Internationale Zeitschrift fur Rehabilitationsforschung. Revue internationale de recherches de readaptation.

Effects of terguride on anterior pituitary function in parkinsonian patients treated with L-dopa: a double-blind study versus placebo.

R. Horowski, G. Nappi, A. Liuzzi, 1996, Clinical neuropharmacology.

Impairment of GH responsiveness to combined GH‐releasing hormone and arginine administration in adult patients with Prader‐Willi syndrome

P. Marzullo, A. Liuzzi, A. Sartorio, 2006, Clinical endocrinology.

TECNOB Study: Ad Interim Results of a Randomized Controlled Trial of a Multidisciplinary Telecare Intervention for Obese Patients with Type-2 Diabetes

E. Molinari, M. Petroni, G. Castelnuovo, 2011, Clinical practice and epidemiology in mental health : CP & EMH.

Effectiveness.of the dopamine agonist lisuride in the treatment of acromegaly and pathological hyperprolactinemic states

R. Horowski, A. Liuzzi, F. Favales, 1980, Journal of endocrinological investigation.

Lisuride hydrogen maleate: evidence for a long lasting dopaminergic activity in humans.

R. Horowski, A. Liuzzi, G. Colussi, 1978, The Journal of clinical endocrinology and metabolism.

Weight cycling and cardiovascular risk factors in obesity

A. Liuzzi, L. Cattani, M. Petroni, 2004, International Journal of Obesity.

Growth hormone therapy improves exercise capacity in adult patients with Prader-Willi syndrome

P. Marzullo, A. Liuzzi, R. Vettor, 2008, Journal of endocrinological investigation.

Rosiglitazone is more effective than metformin in improving fasting indexes of glucose metabolism in severely obese, non‐diabetic patients

A. Caumo, A. Liuzzi, A. Brunani, 2008, Diabetes, obesity & metabolism.

Serum Adiponectin Levels in Advanced-Stage Parkinson's Disease Patients

S. Maestrini, A. Liuzzi, G. Pezzoli, 2011, Parkinson's disease.

Role of insulin-like growth factor (IGF)-1 in the modulation of renal haemodynamics in Type I diabetic patients

A. Di Giorgio, A. Liuzzi, S. De Cosmo, 2000, Diabetologia.

Short-term effects of a hypocaloric diet and a physical activity programme on weight loss and exercise capacity in obese subjects with chronic ischaemic heart disease: a study in everyday practice

G. Augello, A. Liuzzi, C. Parisio, 2008, Acta cardiologica.

A thyroid hormone receptor β gene polymorphism associated with Graves’ disease

A. Liuzzi, V. Tassi, M. Torlontano, 1995 .

Rare melanocortin-3 receptor mutations with in vitro functional consequences are associated with human obesity.

K. Clément, P. Galan, S. Hercberg, 2011, Human molecular genetics.

Lymphocytes and immunoglobulin patterns across the threshold of severe obesity

P. Marzullo, A. Liuzzi, M. Scacchi, 2014, Endocrine.

SerumAdiponectin Levels in Advanced-Stage Parkinson ’ s Disease Patients

A. Liuzzi, G. Pezzoli, A. Blasio, 2011 .

Paraoxonase activity in high-density lipoproteins: a comparison between healthy and obese females.

A. Liuzzi, G. Ferretti, T. Bacchetti, 2005, The Journal of clinical endocrinology and metabolism.

Free and bound plasma leptin in normal weight and obese men and women: relationship with body composition, resting energy expenditure, insulin‐sensitivity, lipid profile and macronutrient preference

P. Magni, G. Savia, A. Liuzzi, 2005, Clinical endocrinology.

Chronic treatment of pathological hyperprolactinemia and acromegaly with the new ergot derivative terguride.

R. Horowski, A. Liuzzi, R. Cozzi, 1986, The Journal of clinical endocrinology and metabolism.

EFFECT OF DOPAMINE INFUSION ON PLASMA LEVELS OF GROWTH HORMONE IN NONMAL SUBJECTS AND IN AGROMEGALIC PATIENTS

A. Liuzzi, G. Colussi, E. Müller, 1976, Clinical endocrinology.

Decreased plasma growth hormone (GH) levels in acromegalics following CB 154(2-Br-alpha ergocryptine) administration.

A. Liuzzi, E. Müller, G. Cremascoli, 1974, The Journal of clinical endocrinology and metabolism.

DECREASED PLASMA GROWTH HORMONE (GH) LEVELS IN ACROMEGALICS FOLLOWING CB 154(2-Br-α-ERGOCRYPTINE) ADMINISTRATION1

A. Liuzzi, E. Müller, G. Cremascoli, 1974 .

Lack of association between the tetranucleotide repeat polymorphism in the 3′-flanking region of the leptin gene and hypertension in severly obese patients

P. Marzullo, S. Maestrini, G. Savia, 2006 .

Lack of association between UCP2 gene polymorphisms and obesity phenotype in Italian Caucasians

S. Maestrini, G. Savia, F. Podestà, 2003, Journal of endocrinological investigation.

The A19G polymorphism in the 5' untranslated region of the human obese gene does not affect leptin levels in severely obese patients.

G. Savia, A. Liuzzi, G. Calo’, 2000, The Journal of clinical endocrinology and metabolism.

Acylated ghrelin decreases during acute exercise in the lean and obese state

P. Marzullo, G. Savia, A. Liuzzi, 2008, Clinical endocrinology.

Bone mineral density in acromegaly: the effect of gender, disease activity and gonadal status

G. Arnaldi, M. Gasperi, A. Colao, 2003, Clinical endocrinology.

Bone mineral density in acromegaly: Does growth hormone excess protect against osteoporosis?

I. Chiodini, A. Liuzzi, V. Trischitta, 2001, Journal of endocrinological investigation.

Revised vs original QUICKI index during diet + rosiglitazone treatment in obese subjects.

A. Caumo, A. Liuzzi, A. Brunani, 2004, Diabetes & metabolism.

BROMOCRIPTINE AND PITUITARY TUMOURS

A. Liuzzi, F. Favales, R. Cozzi, 1979, The Lancet.

Inhibitory effect of dopaminergic stimulation on GH release in acromegaly.

A. Liuzzi, G. Cremascoli, F. Silvestrini, 1974, The Journal of clinical endocrinology and metabolism.

Inhibitory effect of L-Dopa on GH release in acromegalic patients.

A. Liuzzi, G. Cremascoli, F. Silvestrini, 1972, The Journal of clinical endocrinology and metabolism.

Prolactin and pituitary tumors.

A. Liuzzi, F. Silvestrini, P. Chiodini, 1978, Current topics in experimental endocrinology.

Inhibitory effect of an ergoline derivative, methergoline, on growth hormone and prolactin levels in acromegalic patients.

A. Liuzzi, G. Cremascoli, E. Muller, 1976, The Journal of clinical endocrinology and metabolism.

Stable reduction of plasma growth hormone (hGH) levels during chronic administration of 2-Br-alpha-ergocryptine (CB-154) in acromegalic patients.

A. Liuzzi, E. Müller, F. Silvestrini, 1975, The Journal of clinical endocrinology and metabolism.

Letter: Treatment of acromegaly.

A. Liuzzi, E. Müller, F. Silvestrini, 1975, Lancet.

Prevalence of thyroid diseases in patients with acromegaly: results of an Italian Multi-center Study

S. Mariotti, M. Gasperi, E. Martino, 2002, Journal of endocrinological investigation.

Growth hormone (GH)-releasing activity of TRH and GH-lowering effect of dopaminergic drugs in acromegaly: homogeneity in the two responses.

A. Liuzzi, E. Müller, F. Silvestrini, 1974, The Journal of clinical endocrinology and metabolism.

Persistence of somatostatinergic tone in acromegaly.

I. Chiodini, A. Liuzzi, P. Orlandi, 1995, European journal of endocrinology.

Resistance to a long-acting somatostatin analog (SMS 201-995) reversed by surgery in acromegaly

A. Liuzzi, P. Orlandi, R. Attanasio, 1990, Journal of endocrinological investigation.

Medical treatment of acromegaly with SMS 201-995, a somatostatin analog: a comparison with bromocriptine.

A. Liuzzi, E. Pozo, E. D. Del Pozo, 1987, The Journal of clinical endocrinology and metabolism.

Alterations of bone turnover and bone mass at different skeletal sites due to pure glucocorticoid excess: study in eumenorrheic patients with Cushing's syndrome.

A. Di Giorgio, I. Chiodini, A. Scillitani, 1998, The Journal of clinical endocrinology and metabolism.

Skeletal Involvement in Female Acromegalic Subjects: The Effects of Growth Hormone Excess in Amenorrheal and Menstruating Patients

I. Chiodini, A. Scillitani, A. Liuzzi, 1997, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Cushing’s disease and marked hyperprolactinemia in a patient with a pituitary macroadenoma: effectiveness of bromocriptine treatment

M. Tagliaferri, A. Liuzzi, P. Loli, 1984, Journal of endocrinological investigation.

Prolactin response to growth hormone-releasing hormone during chronic thyrotropin-releasing hormone infusion in the treatment of amyotrophic lateral sclerosis

A. Liuzzi, P. Orlandi, F. Girotti, 1990, Journal of endocrinological investigation.

Clinical use of the somatostatin analog SMS 201–995 in endocrinology

A. Liuzzi, P. Orlandi, R. Cozzi, 1988, Journal of endocrinological investigation.

Percutaneous ethanol injection of large thyroid cystic nodules.

M. Bisceglia, A. Liuzzi, M. Torlontano, 1996, Thyroid : official journal of the American Thyroid Association.

Radioiodine and percutaneous ethanol injection in the treatment of large toxic thyroid nodule: a long-term study.

A. Liuzzi, V. Trischitta, V. Frusciante, 2000, Thyroid : official journal of the American Thyroid Association.

The brain as a target for adrenocortical steroids: Cognitive implications

E. Sinforiani, G. Nappi, A. Liuzzi, 1992, Psychoneuroendocrinology.

Evaluation of Rosiglitazone Administration on Cardiovascular Function in Severe Obesity

A. Liuzzi, A. Brunani, G. Viberti, 2008, Clinical cardiology.

Serum type III procollagen propeptide levels in acromegalic patients.

A. Liuzzi, I. Santi, R. Cozzi, 1986, The Journal of clinical endocrinology and metabolism.

Medical Treatment of Acromegaly. Dopaminergic Agonists and Long-Acting Somatostatin

A. Liuzzi, R. Cozzi, D. Dallabonzana, 1988 .

Medical treatment of pituitary adenomas: effects on tumor growth

A. Liuzzi, D. Dallabonzana, G. Verde, 1985, Journal of endocrinological investigation.

The value of plasma prolactin levels in the prediction of the responsiveness of growth hormone secretion to bromocriptine and TRH in acromegaly

J. Klijn, S. Lamberts, A. Liuzzi, 1982, European journal of clinical investigation.

CV 205-502 in acromegaly.

A. Liuzzi, P. Orlandi, R. Attanasio, 1993, Acta endocrinologica.

Effects of nomifensine on growth hormone and prolactin secretion in normal subjects and in pathological hyperprolactinemia.

A. Liuzzi, D. Dallabonzana, F. Silvestrini, 1982, The Journal of clinical endocrinology and metabolism.

TREATMENT OF ACROMEGALY

A. Liuzzi, E. Müller, F. Silvestrini, 1975, The Lancet.

Pre-Cushing’s syndrome not recognized by conventional dexamethasone suppression-tests in an adrenal “incidentaloma” patient

A. Liuzzi, A. Scillitani, M. Torlontano, 1997, Journal of endocrinological investigation.

Stimulation of growth hormone release by thyrotropin-releasing hormone in the hypophysectomized rat bearing an ectopic pituitary.

D. Cocchi, A. Liuzzi, A. Panerai, 1976, Endocrinology.

Size reduction of macroprolactinomas by bromocriptine or lisuride treatment.

R. Horowski, A. Liuzzi, G. Borghi, 1981, The Journal of clinical endocrinology and metabolism.

Oxidation of ferrous sulfate by high-energy electrons and the influence of the polarization effect.

J. S. Laughlin, A. Liuzzi, J. Zsula, 1957, Radiation research.

Low doses of dopamine agonists in the long-term treatment of macroprolactinomas.

A. Liuzzi, R. Cozzi, D. Dallabonzana, 1985, The New England journal of medicine.

Sporadic mutations in melanocortin receptor 3 in morbid obese individuals

M. Petroni, S. Maestrini, M. Tagliaferri, 2008, European Journal of Human Genetics.

The relation between two polymorphisms in the glucocorticoid receptor gene and body mass index, blood pressure and cholesterol in obese patients

S. Maestrini, S. Lamberts, F. Podestà, 2003, Clinical endocrinology.

Contribution of weight cycling to serum leptin in human obesity

G. Savia, S. Bertoli, A. Liuzzi, 2001, International Journal of Obesity.

Serum leptin concentration in moderate and severe obesity: relationship with clinical, anthropometric and metabolic factors

M. Petroni, G. Savia, M. Tagliaferri, 1999, International Journal of Obesity.

Genetic evidence of assortative mating in humans

Tanya M. Teslovich, Ross M. Fraser, Brendan P. Zietsch, 2017, Nature Human Behaviour.

Reenlargement of macroprolactinomas during bromocriptine treatment: report of two cases

C. Tonon, A. Liuzzi, D. Dallabonzana, 1983, Journal of endocrinological investigation.

Microprolactinomas: Why requiem for surgery?

A. Liuzzi, G. Oppizzi, Antonio Liuzzi, 1996, Journal of endocrinological investigation.

SIZE REDUCTION OF A PROLACTIN SECRETING ADENOMA DURING LONG‐TERM TREATMENT WITH THE DOPAMINE AGONIST LISURIDE

R. Horowski, A. Liuzzi, R. Cozzi, 1980, Clinical endocrinology.

The effect of cesium-137 gamma rays on regeneration in tubularia.

A. Liuzzi, F. C. Rose, M. Slaughter, 1970, The Biological Bulletin.

Radiation quality and x-ray emulsion responses☆

A. Liuzzi, A. Goren, L. Pentel, 1969 .

Changes in growth hormone (GH) secretion induced by human pancreatic GH releasing hormone-44 in acromegaly: a comparison with thyrotropin-releasing hormone and bromocriptine.

A. Liuzzi, D. Dallabonzana, G. Verde, 1985, The Journal of clinical endocrinology and metabolism.

Subclinical hypothyroidism in obese patients: relation to resting energy expenditure, serum leptin, body composition, and lipid profile.

G. Savia, M. Tagliaferri, A. Liuzzi, 2001, Obesity research.

An Up-to-Date Vision on the Aetiology and on the Epidemiology of Obesity and Morbid Obesity

A. Liuzzi, Anna Maria Blasio, 2013 .

Thyroperoxidase microsatellite polymorphism in thyroid diseases.

A. Liuzzi, V. Tassi, A. Scillitani, 1995, Thyroid : official journal of the American Thyroid Association.

Effect of Octreotide on Neuroenolase Levels in Patients with Small Cell Lung Cancer

A. Liuzzi, G. Invernizzi, G. Schiraldi, 1994, Tumori.

Effect of chronic bromocriptine administration on tumor size in patients with “nonsecreting” pituitary adenomas

A. Liuzzi, D. Dallabonzana, G. Verde, 1985, Journal of endocrinological investigation.

Molecular and morphologic characterization of superficial‐ and deep‐subcutaneous adipose tissue subdivisions in human obesity

Davide Corà, Michele Caselle, Davide Gentilini, 2013, Obesity.

Permanence of molecular features of obesity in subcutaneous adipose tissue of ex-obese subjects

P. Vitti, C. Invitti, M. Maffei, 2013, International Journal of Obesity.

ANALYSIS OF MULTI-CHANNEL GAMMA RAY SPECTROMETER DATA WITH ADJUSTMENT FOR GAIN AND BASELINE DISCREPANCIES.

B. Pasternack, A. Liuzzi, 1967 .

Some experimental sampling results for regression analysis applied to gamma ray spectrometer data, II.

B. Pasternack, A. Liuzzi, 1968, Biometrics.

Clinical results of long‐term slow‐release lanreotide treatment of acromegaly

G. Gussoni, A. Liuzzi, G. Delitala, 1997, European journal of clinical investigation.

Effect of ergot alkaloids on growth hormone and prolactin secretion in humans.

A. Liuzzi, F. Silvestrini, P. Chiodini, 1978, Pharmacology.

Long-term treatment with 2-Br-alpha-ergocryptine in acromegaly.

A. Liuzzi, G. Molinatti, E. Müller, 1977, Acta endocrinologica.

Thyroid hypoechogenicity after methimazole withdrawal in Graves' disease: a useful index for predicting recurrence?

I. Chiodini, A. Liuzzi, M. Torlontano, 1996, Clinical endocrinology.

TSH receptor antibodies and ultrasonography in Graves' disease

A. Liuzzi, M. Zingrillo, 1995, Clinical endocrinology.

Growth hormone-releasing hormone infusion in patients with active acromegaly.

M. Losa, J. Schopohl, A. Liuzzi, 1986, The Journal of clinical endocrinology and metabolism.

Doxorubicine for acromegaly: a case report

E. Maccagnano, A. Liuzzi, P. Orlandi, 1991, Journal of endocrinological investigation.

Long-term results with the slow-release formulation of lanreotide in acromegalic patients

G. Gussoni, M. Arosio, A. Liuzzi, 1997 .

Evidence for octreotide subcutaneously in the treatment of acromegaly.

A. Liuzzi, G. Oppizzi, 1997, The Journal of endocrinology.

The role of prolactin in the inhibitory action of bromocriptine on growth hormone secretion in acromegaly.

J. Klijn, S. Lamberts, A. Liuzzi, 1983, Acta endocrinologica.

Dopaminergic treatment of acromegaly: different effects on hormone secretion and tumor size.

C. Tonon, A. Liuzzi, G. Borghi, 1984, The Journal of clinical endocrinology and metabolism.

Bromocriptine does not alter growth hormone (GH) responsiveness to GH-releasing hormone in acromegaly.

A. Liuzzi, R. Cozzi, D. Dallabonzana, 1986, The Journal of clinical endocrinology and metabolism.

Subcutaneous Abdominal Adipose Tissue Subcompartments: Potential Role in Rosiglitazone Effects

P. Marzullo, S. Maestrini, A. Liuzzi, 2008, Obesity.

Deep Subcutaneous Adipose Tissue: A Distinct Abdominal Adipose Depot

Paolo Marzullo, P. Marzullo, A. Liuzzi, 2007, Obesity.

Mapping an obesity clinical evaluation protocol to the International Classification of Functioning, Disability and Health

M. Leonardi, A. Raggi, A. Liuzzi, 2010, Disability and rehabilitation.

A simple tool to predict exercise capacity of obese patients with ischaemic heart disease

A. Liuzzi, G. Leonetti, F. Nibbio, 2005, Heart.

A large, nonfunctioning parathyroid cyst recurring after aspiration and subsequently cured by percutaneous ethanol injection

A. Liuzzi, M. Ghiggi, M. Zingrillo, 1996, Journal of clinical ultrasound : JCU.

Predictors of postabsorptive ghrelin secretion after intake of different macronutrients.

P. Marzullo, S. Maestrini, G. Savia, 2006, The Journal of clinical endocrinology and metabolism.

Obesity: a disabling disease or a condition favoring disability?

P. Capodaglio, A. Liuzzi, 2013, European journal of physical and rehabilitation medicine.

The deposition and clearance of radioactive particles in the human lung.

M. Lippmann, R. Albert, A. Liuzzi, 1967, Archives of environmental health.

Conditional cardiovascular response to growth hormone therapy in adult patients with Prader-Willi syndrome.

P. Marzullo, A. Liuzzi, R. Vettor, 2007, The Journal of clinical endocrinology and metabolism.

The nicotinic acetylcholine receptor α7 in subcutaneous mature adipocytes: downregulation in human obesity and modulation by diet-induced weight loss

S. Maestrini, C. Invitti, A. Liuzzi, 2012, International Journal of Obesity.

High prevalence of risk factors for cardiovascular disease in parents of IDDM patients with albuminuria

M. Margaglione, R. Giorgino, A. Liuzzi, 1997, Diabetologia.

Investigations of thyroid hormones and antibodies in obesity: leptin levels are associated with thyroid autoimmunity independent of bioanthropometric, hormonal, and weight-related determinants.

P. Marzullo, M. Tagliaferri, A. Liuzzi, 2010, The Journal of clinical endocrinology and metabolism.

Leptin plasma concentrations are dependent on body fat distribution in obese patients

M. Petroni, G. Savia, M. Tagliaferri, 2000, International Journal of Obesity.